WO2003064576A2 - High linolenic acid flax - Google Patents

High linolenic acid flax Download PDF

Info

Publication number
WO2003064576A2
WO2003064576A2 PCT/CA2003/000116 CA0300116W WO03064576A2 WO 2003064576 A2 WO2003064576 A2 WO 2003064576A2 CA 0300116 W CA0300116 W CA 0300116W WO 03064576 A2 WO03064576 A2 WO 03064576A2
Authority
WO
WIPO (PCT)
Prior art keywords
flax
acid content
seed
linolenic acid
linolenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA2003/000116
Other languages
English (en)
French (fr)
Other versions
WO2003064576A8 (en
Inventor
Edward O. Kenaschuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture and Agri-Food Canada
Original Assignee
Agriculture and Agri-Food Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agriculture and Agri-Food Canada filed Critical Agriculture and Agri-Food Canada
Priority to AU2003203073A priority Critical patent/AU2003203073B2/en
Priority to EP03701378A priority patent/EP1471784A2/en
Priority to JP2003564173A priority patent/JP2005515774A/ja
Publication of WO2003064576A2 publication Critical patent/WO2003064576A2/en
Publication of WO2003064576A8 publication Critical patent/WO2003064576A8/en
Anticipated expiration legal-status Critical
Priority to NZ534822A priority patent/NZ534822A/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H5/00Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
    • A01H5/10Seeds

Definitions

  • the present invention relates generally to the field of agriculture. More specifically, the present invention relates to flax seeds, plants and oils having altered fatty acid profiles.
  • Unsaturated fatty acids consist of monosaturates and polyunsaturates (PuFA).
  • PuFA's There are two classes of PuFA's, omega-3 and omega-6 which are considered as essential fatty acids (EFA) because humans, like all mammals, cannot synthesize them and most obtain them in their diet.
  • Omega-3 is represented by alpha-linolenic acid (LNA) and linseed flax has the highest linolenic content of major seed oils.
  • LNA is metabolized to eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA), increasing the chain length and degree of unsaturation by adding double bonds to the carboxyl group. Humans and animals can convert LNA to EPA and DHA.
  • Essential fatty acids have several vital functions: they increase metabolic rate, improve metabolism, increase oxygen uptake and increase energy production.
  • EPA and their derivatives are components of membranes surrounding cells; they are required for the transport and metabolism of cholesterol and triglycerides; they are required for normal development of the brain and for brain function in adults; and from EPA's the body makes hormone-like substances called prostaglandins which have important regulating functions in the body, i.e. they regulate arterial muscle tone, sodium excretion through the kidneys, platelet
  • omega-3 fatty acids may play an important role in the prevention and treatment of coronary artery disease, hypertension, diabetes, arthritis, and other inflammatory
  • Linseed flax is grown primarily for its oil which has many industrial
  • Linseed oil is also used as an anti-spalling and curing agent for concrete surfaces including highways and bridges.
  • Linseed oil is used as an industrial oil because of its drying property, i.e. ability to dry rapidly to form a durable film upon exposure to air.
  • the drying property of linseed oil is due to the high content of unsaturated fatty acids, particularly linolenic acid.
  • the linolenic content of Canadian flax cultivars varies from 49-62% depending on cultivar and growing conditions. Temperature during seed formation and photoperiod influences the degree of unsaturation of the fatty acid in linseed oil. Cool temperatures and longer photoperiod increases linolenic content. Other factors which may affect the variability of linolenic content are soil moisture, soil fertility and presence of disease.
  • High linolenic flax oil provides a valuable improved source of omega- 3 fatty acid for human nutrition, animal feed and pet foods.
  • a flax seed having a linolenic acid content of greater than 65% of the total fatty acid content of said seed.
  • a flax seed that is the product of a plant line designated M5791.
  • a flax plant which produces seeds having a linolenic acid content of greater than 65% of the total fatty acid content of said seed.
  • a flax plant designated M5791 According to a fourth aspect of the invention, there is provided a flax plant designated M5791.
  • progeny of a flax plant designated M5791 wherein said progeny produce seeds having a linolenic acid content of greater than 65% of the total fatty acid content of said seed.
  • a method of producing a flax plant line comprising the steps of:
  • TABLE 1 shows the fatty acid composition of major seed oils.
  • TABLE 2 shows fatty acid composition and iodine value of linseed flax and high linolenic flax (M 5791 ).
  • TABLE 5 shows the analysis of linolenic acid content of M5791.
  • FIGURE 1 shows the structural formula for fatty acids.
  • the first number (before the colon) gives the number of carbon atoms in the molecule and the second gives the number of double bonds.
  • ⁇ 3, ⁇ 6, and ⁇ 9 indicate the position of the first double bond in a given fatty acid molecule.
  • FIGURE 2 shows the elongation and desaturation of n-6 and n-3 polyunsaturated fatty acids.
  • FIGURE 3 shows the pedigree of high linolenic flax M 5791. DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • high linolenic flax refers to flax seeds or plants wherein the percentage of total fatty acid content that is linolenic acid is greater than 65%.
  • inflammatory disease refers to diseases that are associated with an inappropriate or over-activation of the inflammation cascade.
  • autoimmune disorder refers to diseases characterized by destruction of host tissue by the host immune system.
  • the invention relates to flax seeds, plants or products made therefrom wherein linolenic acid is greater than 65% of the total fatty acid content.
  • the linolenic acid content may be greater than 70% of the total fatty acid content. In yet other embodiments, the linolenic acid content may be 70-80% or 70-75% of the total fatty acid content.
  • M5791 As discussed herein, the crossing of flax lines has produced a high linolenic flax line, designated M5791. As shown in Tables 4 and 5, M5791 shows much higher linolenic acid content relative to other flax lines. As will be appreciated by one knowledgeable in the art, and as discussed herein, growth conditions can affect linolenic acid content. However, flax line M5791 can be grown and processed using means known in the art for growing and processing flax.
  • the linolenic content of M 5791 oil is not altered by any methods of extraction of oil from seed, i.e. solvent, cold press, or distillation.
  • flax and/or linseed oil have are present in a number of industrial, nutritional and medicinal products.
  • linseed oil is used as an industrial oil because of its drying properties, which are in turn directly proportional to the linolenic acid content.
  • Industrial uses of this oil include but are by no means limited to the manufacture of brake linings, adhesives, manufacture of hardboard and fibreboard, protective coatings, paints, house paint primers, varnishes, lacquers, stains, alkyd resins, enamels, epoxidized oils, floor coverings, linoleum, oilcloth, tarpaulin and other coated fabrics, patent leather, industrial chemical, fatty acids, soap, glycerin, printing inks, grinding oils, newsprint, core oils, caulking compounds, waterproofing compounds, mastic cements, foundry binders, brake lining, hardboard, shoe polish, herbicide, pesticide carrier, antispalling and curing treatments for concrete, tempering oil, bonding oil, and highly conjugated oils for hardboards and the like.
  • linseed oil from high linolenic acid flax will result in, for examples, faster drying paints, coatings, inks and the like.
  • industrial uses of linseed oil include but are by no means limited to US Patents 5,965,633, 5,693,715, 5,653,789, 3,488,202 and 4,002,585.
  • the meal remaining from the flax seed oil extraction includes but are by no means limited to US Patents 5,965,633, 5,693,715, 5,653,789, 3,488,202 and 4,002,585.
  • meal from the high linolenic acid flax seeds may be used in any application known in the art for using meal from flax seeds, wherein the meal has the added benefit of having a
  • the above-described flax seed may be used, for example, to
  • the seed, oil, or meal may be used in feed for dairy and beef cattle, swine and/or poultry to increase levels of linolenic acid in the resulting food products, for example, eggs, meat and milk.
  • the seed and meal may also be used in pet foods.
  • the seed and oil may also be used as a source of linolenic acid for growing fish.
  • polyunsatu rated fats for example, linolenic acid are essential fatty acids and are required for increased metabolism, oxygen uptake, and energy production.
  • nutritional supplements or food products containing material produced or processed from the high linolenic acid flax line would be higher in polyunsatu rated fats and therefore of greater benefit.
  • the high linolenic flax line, seeds or products derived therefrom can be used in, for
  • linolenic acid also plays a role in the prevention and/or treatment of a number of diseases, including , for example, coronary artery disease, hypertension, diabetes, arthritis and other inflammatory or autoimmune disorders.
  • supplements or pharmaceutical compositions including material derived from the high linolenic acid flax are prepared and used to treat and/or prevent the above-referenced diseases or disorders.
  • Examples of medicinal uses for flax and/or linseed oil include but are by no means limited to US Patents 5,859,055, 4,415,554, 5,468,776 and 4,058,594.
  • the high linolenic linseed oil or high linolenic flax may be included in a tablet, capsule, tincture, salve, paste, cream or the like.
  • the high linolenic acid flax or linseed oil therefrom at therapeutically effective concentrations or dosages may be combined with a pharmaceutically or pharmacologically acceptable carrier, excipient or diluent, either biodegradable or non-biodegradable.
  • Exemplary examples of earners include, but are by no means limited to, for example, poly(ethylene-vinyl acetate), copolymers of lactic acid and glycolic acid, poly(lactic acid), gelatin, collagen matrices, polysaccharides, poly(D,L lactide), poly(malic acid), poly(caprolactone), celluloses, albumin, starch, casein, dextran, polyesters, ethanol, mathacrylate, polyurethane, polyethylene, vinyl polymers, glycols, mixtures thereof and the like.
  • Standard excipients include gelatin, casein, lecithin, gum acacia, cholesterol, tragacanth, stearic acid, benzalkonium chloride, calcium stearate, glyceryl monostearate, cetostearyl alcohol, cetomacrogol emulsifying wax, sorbitan esters, polyoxyethylene alkyl ethers, polyoxyethylene castor oil derivatives, polyoxyethylene sorbitan fatty acid esters, polyethylene glycols, polyoxyethylene stearates, colloidol silicon dioxide, phosphates, sodium dodecylsulfate, carboxymethylcellulose calcium, carboxymethylcellulose sodium, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethycellulose phthalate, noncrystalline cellulose, magnesium aluminum silicate, triethanolamine, polyvinyl alcohol, polyvinylpyrrolidone, sugars and starches. See, for example, Remington: The Science and Practice of
  • oil from the seeds of the high linolenic acid is obtained from the seeds of the high linolenic acid
  • flax plants are used as carriers or diluents for other pharmaceutical or medicinal compounds.
  • the high linolenic acid flax line, seeds therefrom or products derived therefrom can be used in the production of any flax-containing products known in the art. As will be appreciated by one knowledgeable in the art, these products will have the added benefit of having a higher linolenic acid content.
  • the flax plant designated M5791 can be used to perform genetic crosses with other flax lines using means known in the art.
  • High Linolenic flax was developed by conventional plant breeding, ie. hybridization using cultivars, breeding lines and accessions, and selections for high linolenic acid content in segregating populations from crosses, at the AAFC Morden Research Centre, Morden, MB. The development of High Linolenic flax
  • F6 lines were selected for high linolenic content at Morden and seed harvested in bulk. Seed of F7 lines was increased in a winter nursery. High linolenic flax was evaluated in replicated trials conducted in 1998, 1999 and 2000, and in field trials conducted in 1998 and 1999 (Table 5).
  • Linolenic acid content determined by gas-liquid chromatography of the fatty acid esters using the method described by Daun et al., J. Amer. Oil Chemists' Society, 60, 1983. Table 6. Linolenic Acid Content of High Linolenic Flax (M 5791) in Field Trials, 1998 & 1999
  • Linseed Oil Adhesives i.e. manufacture of hardboard and fibreboard
  • Raw & Refined Floor Covering linoleum Boiled & Blown Oilcloth, tarpaulin and other coated fabrics Grinding Oils Patent leather Heat Boiled Industrial Chemicals: fatty acids, soap, glycerin
  • Seed, oil, meal Dairy and beef cattle, swine and poultry feed and also to increase levels of linolenic acid in food products, i.e. eggs, meat and milk

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Fats And Perfumes (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
PCT/CA2003/000116 2002-01-30 2003-01-30 High linolenic acid flax Ceased WO2003064576A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2003203073A AU2003203073B2 (en) 2002-01-30 2003-01-30 High linolenic acid flax
EP03701378A EP1471784A2 (en) 2002-01-30 2003-01-30 High linolenic acid flax
JP2003564173A JP2005515774A (ja) 2002-01-30 2003-01-30 高リノレン酸亜麻
NZ534822A NZ534822A (en) 2002-01-30 2004-08-19 Flax seed used to produce oil comprising a specified linolenic acid content

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/059,080 2002-01-30
US10/059,080 US6870077B2 (en) 2002-01-30 2002-01-30 High linolenic acid flax

Publications (2)

Publication Number Publication Date
WO2003064576A2 true WO2003064576A2 (en) 2003-08-07
WO2003064576A8 WO2003064576A8 (en) 2004-03-18

Family

ID=27658245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2003/000116 Ceased WO2003064576A2 (en) 2002-01-30 2003-01-30 High linolenic acid flax

Country Status (7)

Country Link
US (2) US6870077B2 (enExample)
EP (1) EP1471784A2 (enExample)
JP (1) JP2005515774A (enExample)
CN (1) CN1642410A (enExample)
AU (1) AU2003203073B2 (enExample)
NZ (1) NZ534822A (enExample)
WO (1) WO2003064576A2 (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7922811B2 (en) 2005-06-02 2011-04-12 W. R. Grace & Co.-Conn. Biomass-derived grinding aids
EP2701698A4 (en) * 2011-04-26 2014-10-15 Retrotope Inc DISEASES WITH PUFA OXIDATION
WO2018104596A1 (fr) * 2016-12-09 2018-06-14 Etablissements Andre Laboulet Plantes de lin a haute teneur en omega-3
US10052299B2 (en) 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
US10058612B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
US10058522B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Oxidative retinal diseases
US10154983B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
US11447441B2 (en) 2015-11-23 2022-09-20 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
US11779910B2 (en) 2020-02-21 2023-10-10 Biojiva Llc Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10151155A1 (de) * 2001-10-19 2003-05-08 Nutrinova Gmbh Native PUFA-Triglyceridmischungen mit einem hohen Gehalt an mehrfach ungesättigten Fettsäuren sowie Verfahren zu deren Herstellung und deren Verwendung
US6870077B2 (en) * 2002-01-30 2005-03-22 Edward O. Kenaschuk High linolenic acid flax
US20050132441A1 (en) 2003-11-12 2005-06-16 Damude Howard G. Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
RU2008122057A (ru) * 2005-11-03 2009-12-10 Лиллиан ПИТЕРСОН (CA) Высоколиноленовые композиции льняного масла
US20080069942A1 (en) * 2006-09-15 2008-03-20 Glenn Roy Pizzey Flax-stabilized fatty acid compositions and methods
JP2010524493A (ja) * 2007-04-29 2010-07-22 シェメン インダストリーズ リミテッド 乳児および幼児のための栄養供給用油組成物
AU2009226019C1 (en) 2008-03-20 2014-02-20 Virun, Inc. Emulsions including a PEG-derivative of tocopherol
CN103190631B (zh) 2008-03-20 2016-01-20 维尔恩公司 非水性预乳液组合物及制备包含植物甾醇的饮料的方法
US8337931B2 (en) * 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
US20120237658A1 (en) * 2009-09-10 2012-09-20 Cargil, Incorporated Oxidatively stable fats with elevated alpha-linolenic acid content
CN103037708B (zh) * 2010-03-23 2015-05-20 维尔恩公司 含有蔗糖脂肪酸酯的纳米乳液
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
WO2013120025A1 (en) 2012-02-10 2013-08-15 Virun, Inc. Beverage compositions containing non-polar compounds
AU2014235283B2 (en) 2013-03-15 2017-06-01 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
WO2016044805A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
CA3054548A1 (en) * 2016-02-26 2017-08-31 Nathan Golas High alpha linolenic acid flax
FR3073711B1 (fr) * 2017-11-21 2021-03-12 Valorex Sa Procede de traitement de graines de lin en vue d'ameliorer leur valorisation a titre d'aliments
EP3693180B1 (en) 2019-02-05 2023-09-13 Flooring Industries Limited, SARL Method for manufacturing a decorative foil and a panel comprising such foil

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069903A (en) * 1987-12-16 1991-12-03 Stitt Paul A Therapeutic and nutritive flax seed composition and methods employing the same
DE4042354A1 (de) * 1990-09-21 1992-03-26 Allkraft Futtermittel Gmbh Futtermittel aus leinsamen
CA2124673C (en) 1991-12-04 2008-08-05 John Browse Fatty acid desaturase genes from plants
US5288805A (en) * 1992-08-14 1994-02-22 Cargill, Incorporated Linseed oil based polymeric vehicle
US5653789A (en) * 1994-05-23 1997-08-05 Permagrain Products, Inc. Water base conditioner for acrylic wood flooring
US6060101A (en) * 1994-09-02 2000-05-09 Designing Health, Inc. Dietary food supplement
DE19941609A1 (de) 1999-09-01 2001-03-08 Inst Pflanzenbiochemie Ipb Fettsäure-Desaturase-Gen aus Pflanzen
US20030131737A1 (en) * 2001-12-13 2003-07-17 Wuwei Cui Process and apparatus for flaxseed component separation
US6870077B2 (en) * 2002-01-30 2005-03-22 Edward O. Kenaschuk High linolenic acid flax

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No Search *
See also references of EP1471784A2 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328021B2 (en) 2005-06-02 2016-05-03 Gcp Applied Technologies Inc. Biomass derived grinding aids
US7922811B2 (en) 2005-06-02 2011-04-12 W. R. Grace & Co.-Conn. Biomass-derived grinding aids
US10052299B2 (en) 2009-10-30 2018-08-21 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
US11510888B2 (en) 2009-10-30 2022-11-29 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
USRE49238E1 (en) 2009-10-30 2022-10-11 Retrotope, Inc. Alleviating oxidative stress disorders with PUFA derivatives
US10154983B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
US11285125B2 (en) 2011-04-26 2022-03-29 Retrotope, Inc. Oxidative retinal diseases
US10058612B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
US10058522B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Oxidative retinal diseases
US10154978B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Disorders implicating PUFA oxidation
US12156860B2 (en) 2011-04-26 2024-12-03 Biojiva Llc Disorders implicating PUFA oxidation
US11241409B2 (en) 2011-04-26 2022-02-08 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
EP2701698A4 (en) * 2011-04-26 2014-10-15 Retrotope Inc DISEASES WITH PUFA OXIDATION
AU2012249920B2 (en) * 2011-04-26 2017-06-15 Biojiva Llc Disorders implicating PUFA oxidation
US11453637B2 (en) 2015-11-23 2022-09-27 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
US11447441B2 (en) 2015-11-23 2022-09-20 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
US12060324B2 (en) 2015-11-23 2024-08-13 Biojiva Llc Site-specific isotopic labeling of 1,4-diene systems
FR3059870A1 (fr) * 2016-12-09 2018-06-15 Etablissements Andre Laboulet Plantes de lin a haute teneur en omega-3
WO2018104596A1 (fr) * 2016-12-09 2018-06-14 Etablissements Andre Laboulet Plantes de lin a haute teneur en omega-3
US11779910B2 (en) 2020-02-21 2023-10-10 Biojiva Llc Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Also Published As

Publication number Publication date
US6870077B2 (en) 2005-03-22
AU2003203073A2 (en) 2003-09-02
JP2005515774A (ja) 2005-06-02
AU2003203073B2 (en) 2008-05-15
NZ534822A (en) 2008-06-30
US20030159172A1 (en) 2003-08-21
CN1642410A (zh) 2005-07-20
US20050198709A1 (en) 2005-09-08
EP1471784A2 (en) 2004-11-03
WO2003064576A8 (en) 2004-03-18
US7763303B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
AU2003203073B2 (en) High linolenic acid flax
AU2003203073A1 (en) High linolenic acid flax
Zanetti et al. Camelina, an ancient oilseed crop actively contributing to the rural renaissance in Europe. A review
Hall et al. Flax (Linum usitatissimum L.)
US8343753B2 (en) Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US8895767B2 (en) Obtaining fatty acids from insect larvae
Pali et al. Evaluation of oil content and fatty acid compositions of flax (Linum usitatissimum L.) varieties of India
Pathak et al. Sesame (Sesamum indicum L.), an underexploited oil seed crop: Current status, features and importance-A review.
Solís-Fuentes et al. Mango (Mangifera indica L.) seed and its fats
Kolodziejczyk et al. The application of flax and hemp seeds in food, animal feed and cosmetics production
US6953882B2 (en) Oil from seeds with a modified fatty acid composition
Solís-Fuentes et al. Mango Seed: Mango (Mangifera indica L.) seed and its fats
Mitiku et al. Breeding for quality traits improvement of mustard (Brassica Juncea)
Gambuś et al. Chemical composition of linseed with different colour of bran layer.
Piętka et al. Double low white mustard (Sinapis alba L. syn. Brassica hirta) is a source of protein and oil.
Reshi et al. Edible Oilseed Plants: An Overview
Arslan et al. Characterization of flax genetic resources in Türkiye through variance analysis of antioxidant, phenolic compound and fatty acid contents
KUMAR An Overview of Utility, Status, Retrospective and Prospects of Castor: A Review.
Lim Helianthus annuus
Tiwari et al. ALSI: Omega-3-Rich Source for Health and Vitality
Downey et al. Breeding for modified fatty acid composition
Tejklova et al. Medium-linolenic linseed (Linum usitatissimum L.) Raciol.
Suter Health and nutrition: Opportunities for linseed in Australian food products
Christou et al. “Non-food Crops-to-Industry schemes in EU27” WP1. Non-food crops
Mohanty et al. Sesame (Sesamum indicum L.) the emerging oilseed crop: Current status, features, importance and breeding objectives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
D17 Declaration under article 17(2)a
WWE Wipo information: entry into national phase

Ref document number: 2003564173

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 534822

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2003701378

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003203073

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 20038060833

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2003701378

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 2003701378

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003701378

Country of ref document: EP